(Judgment) Appeal – Orphan medicinal products – Regulation (EC) No 141/2000 – Regulation (EC) No 847/2000 – Refusal to grant marketing authorisation for the generic version of the orphan medicinal product ‘imatinib mesylate’
C-138/15, [2016] EUECJ C-138/15
Bailii
Regulation (EC) No 141/2000, Regulation (EC) No 847/2000
European
Health
Updated: 12 January 2022; Ref: scu.560968